Apimeds Pharmaceuticals US Inc (APUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 1,844 | 2,664 | 364 | 276 | 300 |
| Operating Income | -1,844 | -2,664 | -364 | -276 | -300 |
| Interest Expense | 6 | 23 | 38 | 36 | 33 |
| Other Income | 69 | 25 | 0 | 0 | 0 |
| Pre-tax Income | -1,781 | -2,662 | -402 | -312 | -333 |
| Net Income Continuous | -1,781 | -2,662 | -402 | -312 | -333 |
| Net Income | $-1,781 | $-2,662 | $-402 | $-312 | $-333 |
| EPS Basic Total Ops | -0.14 | -0.26 | -0.05 | N/A | -0.04 |
| EPS Basic Continuous Ops | -0.14 | -0.26 | -0.05 | N/A | -0.04 |
| EPS Diluted Total Ops | -0.14 | -0.26 | -0.05 | N/A | -0.04 |
| EPS Diluted Continuous Ops | -0.14 | -0.26 | -0.05 | N/A | -0.04 |
| EPS Diluted Before Non-Recurring Items | -0.14 | -0.26 | -0.05 | N/A | N/A |
| EBITDA(a) | $-1,833 | $-2,664 | $-364 | $-276 | $-300 |